• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雷公藤红素的治疗应用和递送系统。

Therapeutic applications and delivery systems for triptolide.

机构信息

School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, SP, Brazil.

出版信息

Drug Deliv Transl Res. 2020 Dec;10(6):1584-1600. doi: 10.1007/s13346-020-00827-z.

DOI:10.1007/s13346-020-00827-z
PMID:32789808
Abstract

Triptolide (TPL) is a natural compound and active component of Tripterygium wilfordii Hook F., an Asian native woody vine widely used for over 200 years in Chinese medicine. Hot water, ethanol-ethyl acetate, and chloroform-methanol extracts are the first reported TPL preparations in the literature, and since then, several studies for application in inflammation processes and cancer are described due to the antitumor, anti-inflammatory, and immunosuppressive characteristics of the molecule. However, physicochemical properties such as poor solubility and bioavailability are the main concerns regarding the TPL safety and efficacy in clinical studies since trials have reported adverse side effects alongside the excellent TPL therapeutic effects. Here, we review the main TPL applications and issues related to the drug usage, and a comprehensive summary of diseases is provided. Special emphasis is given to drug delivery systems designed to overcome the TPL physicochemical characteristics such as poor drug solubility, and how to increase efficacy and obtain a safe drug profile. Graphical abstract.

摘要

雷公藤红素(TPL)是一种天然化合物,也是亚洲本土木质藤本植物雷公藤的活性成分,在中国医学中已使用了 200 多年。热水、乙醇-乙酸乙酯和氯仿-甲醇提取物是文献中首次报道的 TPL 制剂,此后,由于该分子具有抗肿瘤、抗炎和免疫抑制特性,有几项关于在炎症过程和癌症中应用的研究。然而,由于 TPL 在临床研究中的安全性和疗效存在不良副作用,因此 TPL 的理化性质,如溶解度和生物利用度差,是人们关注的主要问题。在这里,我们综述了 TPL 的主要应用及与药物使用相关的问题,并对疾病进行了全面总结。特别强调了旨在克服 TPL 理化特性(如药物溶解度差)的药物传递系统,以及如何提高疗效和获得安全的药物特性。

相似文献

1
Therapeutic applications and delivery systems for triptolide.雷公藤红素的治疗应用和递送系统。
Drug Deliv Transl Res. 2020 Dec;10(6):1584-1600. doi: 10.1007/s13346-020-00827-z.
2
Triptolide: progress on research in pharmacodynamics and toxicology.雷公藤甲素:药效学与毒理学研究进展
J Ethnopharmacol. 2014 Aug 8;155(1):67-79. doi: 10.1016/j.jep.2014.06.006. Epub 2014 Jun 13.
3
Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f.雷公藤甲素的免疫抑制和抗炎机制,雷公藤甲素是中药雷公藤(Tripterygium wilfordii Hook. f.)中的主要活性二萜类化合物
Drugs R D. 2003;4(1):1-18. doi: 10.2165/00126839-200304010-00001.
4
[Advanced progress of main pharmacology activities of triptolide].雷公藤甲素主要药理活性的研究进展
Zhongguo Zhong Yao Za Zhi. 2017 Jul;42(14):2655-2658. doi: 10.19540/j.cnki.cjcmm.20170609.011.
5
The identity of immunosuppressive components of the ethyl acetate extract and chloroform methanol extract (T2) of Tripterygium wilfordii Hook. F.雷公藤(Tripterygium wilfordii Hook. F.)乙酸乙酯提取物和氯仿-甲醇提取物(T2)中免疫抑制成分的鉴定
J Pharmacol Exp Ther. 1995 Mar;272(3):1305-12.
6
Triptolide, an active component of the Chinese herbal remedy Tripterygium wilfordii Hook F, inhibits production of nitric oxide by decreasing inducible nitric oxide synthase gene transcription.雷公藤甲素是中药雷公藤的一种活性成分,它通过降低诱导型一氧化氮合酶基因转录来抑制一氧化氮的产生。
Arthritis Rheum. 2004 Sep;50(9):2995-303. doi: 10.1002/art.20459.
7
Effects of Tripterygium wilfordii hook F extracts on induction of cyclooxygenase 2 activity and prostaglandin E2 production.雷公藤提取物对环氧合酶2活性诱导及前列腺素E2生成的影响。
Arthritis Rheum. 1998 Jan;41(1):130-8. doi: 10.1002/1529-0131(199801)41:1<130::AID-ART16>3.0.CO;2-4.
8
Herbal compound triptolide synergistically enhanced antitumor activity of vasostatin120-180.草药复合物雷公藤红素协同增强了血管抑肽 120-180 的抗肿瘤活性。
Anticancer Drugs. 2013 Oct;24(9):945-57. doi: 10.1097/CAD.0b013e3283651862.
9
Triptolide (TPL) inhibits global transcription by inducing proteasome-dependent degradation of RNA polymerase II (Pol II).雷公藤红素(TPL)通过诱导蛋白酶体依赖性的 RNA 聚合酶 II(Pol II)降解来抑制全局转录。
PLoS One. 2011;6(9):e23993. doi: 10.1371/journal.pone.0023993. Epub 2011 Sep 13.
10
[Comparative clinical study of rheumatoid arthritis treated by triptolide and an ethyl acetate extract of Tripterygium wilfordii].雷公藤甲素与雷公藤乙酸乙酯提取物治疗类风湿关节炎的临床对比研究
Zhong Xi Yi Jie He Za Zhi. 1990 Mar;10(3):144-6, 131.

引用本文的文献

1
attenuates acute lung injury by regulating the differentiation and function of myeloid-derived suppressor cells.通过调节髓源性抑制细胞的分化和功能减轻急性肺损伤。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025 May 28;50(5):840-850. doi: 10.11817/j.issn.1672-7347.2025.240424.
2
Pharmacological modes of plant-derived compounds for targeting inflammation in rheumatoid arthritis: A comprehensive review on immunomodulatory perspective.植物源化合物靶向类风湿关节炎炎症的药理模式:基于免疫调节视角的综述
Inflammopharmacology. 2025 Apr;33(4):1537-1581. doi: 10.1007/s10787-025-01664-7. Epub 2025 Mar 13.
3
A Novel Triptolide Nano-Liposome with Mitochondrial Targeting for Treatment of Hepatocellular Carcinoma.
一种具有线粒体靶向性的新型雷公藤甲素纳米脂质体用于治疗肝细胞癌
Int J Nanomedicine. 2024 Dec 3;19:12975-12998. doi: 10.2147/IJN.S498099. eCollection 2024.
4
Locally Injectable Chitosan/β-Glycerophosphate Hydrogel Doped with Triptolide-Human Serum Albumin Nanoparticles for Treating Rheumatoid Arthritis.负载雷公藤甲素-人血清白蛋白纳米粒的局部可注射壳聚糖/β-甘油磷酸盐水凝胶用于治疗类风湿性关节炎
Pharmaceuticals (Basel). 2024 Oct 1;17(10):1312. doi: 10.3390/ph17101312.
5
The Yin and Yang of the Natural Product Triptolide and Its Interactions with XPB, an Essential Protein for Gene Expression and DNA Repair.天然产物雷公藤内酯的阴阳两面及其与 XPB 的相互作用,XPB 是基因表达和 DNA 修复所必需的蛋白质。
Genes (Basel). 2024 Sep 30;15(10):1287. doi: 10.3390/genes15101287.
6
Advances in cell membrane-based biomimetic nanodelivery systems for natural products.基于细胞膜的仿生纳米递药系统在天然产物中的研究进展。
Drug Deliv. 2024 Dec;31(1):2361169. doi: 10.1080/10717544.2024.2361169. Epub 2024 Jun 3.
7
Therapeutic Potential of Triptolide in Treating Bone-Related Disorders.雷公藤甲素在治疗骨相关疾病中的治疗潜力。
Front Pharmacol. 2022 Jun 15;13:905576. doi: 10.3389/fphar.2022.905576. eCollection 2022.
8
Triptolide improves myocardial fibrosis in rats through inhibition of nuclear factor kappa B and NLR family pyrin domain containing 3 inflammasome pathway.雷公藤甲素通过抑制核因子κB和含NLR家族pyrin结构域蛋白3炎性小体途径改善大鼠心肌纤维化。
Korean J Physiol Pharmacol. 2021 Nov 1;25(6):533-543. doi: 10.4196/kjpp.2021.25.6.533.